Breast, Ovary Removal Can Lengthen Lives of Women With Breast Cancer Genes

Follow Drugslib on

Medically reviewed by Drugs.com.

By Dennis Thompson HealthDay Reporter

FRIDAY, Dec. 13, 2024 -- It's a decision no woman wants to have to make, but new research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning if they have their breasts or ovaries removed.

Breast cancer patients aged 40 or younger with BRCA mutations had a 35% lower risk of death and 42% lower risk of cancer recurrence if they underwent a risk-reducing operation to remove their breasts, according to findings presented this week at the San Antonio Breast Cancer Symposium.

Patients also had a 42% lower risk of death and 32% lower risk of recurrence following removal of their ovaries.

“This global study provides the first evidence that risk-reducing surgeries improve survival outcomes among young BRCA-mutation carriers with a prior history of early-onset breast cancer,” said researcher Dr. Matteo Lambertini, an associate professor of medical oncology at the University of Genova-IRCCS Policlinico San Martino Hospital in Italy.

“We believe that our findings are critical for improving the counseling of BRCA-mutation carriers with early-onset breast cancer on cancer-risk management strategies,” Lambertini added in a meeting news release.

It’s been long known that women with BRCA1 and BRCA2 gene mutations are at higher risk for breast and ovarian cancer.

More than 60% of women who inherit a BRCA mutation will develop breast cancer in their lifetimes, according to the National Cancer Institute (NCI).

Likewise, as many as 58% of women with a BRCA1 mutation and 29% of women with a BRCA2 mutation will develop ovarian cancer, the NCI says.

One strategy to lower these women’s risk of cancer is to remove their “at-risk” tissue – that is, to remove their breasts or ovaries.

This strategy has been shown to help reduce risk in women with BRCA mutations who haven’t had cancer, but its effectiveness hasn’t been tested in young women who’ve already developed breast cancer, Lambertini said.

The negative effects also must be considered, particularly when it comes to ovary removal, Lambertini noted. Ovary removal leads to infertility and early menopause.

“Considering the unique traits and needs of this younger population, and their high risk for secondary malignancies, it is critical to understand how risk-reducing surgeries affect patient outcomes, so that the risks and benefits of these procedures can be carefully weighed,” Lambertini said.

For the new study, researchers analyzed data on nearly 5,300 breast cancer patients with BRCA mutations treated at 109 hospitals across five continents. The women were all diagnosed with breast cancer at age 40 or younger between 2000 and 2020.

Among those patients, nearly 3,900 underwent at least one risk-reducing surgery, including around more than 1,800 who had both their breasts and ovaries removed, researchers said.

Results showed that women with BRCA1 mutations benefitted more than those with BRCA2 mutations, with their risk of death reduced by 56% compared with 15%.

Because these findings were presented at a medical meeting, they should be considered preliminary until published in a peer-reviewed journal.

Sources

  • San Antonio Breast Cancer Symposium, news release, Dec. 11, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-12-14 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords